Brief Report: Children with a history of both maternal immune activation and prematurity are not at increased risk of ADHD-Reference-Cited by-同舟云学术

Brief Report: Children with a history of both maternal immune activation and prematurity are not at increased risk of ADHD

Published:2023-04-07 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Ellul Pierre¹,Wallez Solène²,Acquaviva Eric¹,Rosenzwajg Michelle³,Klatzmann David³,Delorme Richard¹,Melchior Maria²

Affiliation:

1. University of Paris Cité

2. Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, Equipe de Recherche en Epidémiologie Sociale, ERES

3. INSERM U959, Sorbonne University

Abstract

Abstract Maternal autoimmune diseases (AID) are risk factors for Attention Deficit Hyperactivity Disorder (ADHD). Animal studies suggest that maternal immune activation (MIA) is a disease primer for ADHD, with second environmental factor precipitating the onset of the disease. Prematurity is also a major risk factor for ADHD. In this study, we sought to explore the interaction between parental AID and prematurity on ADHD risk in a community sample. Children of AID parents born prematurely appeared at increased odds of ADHD but but these two risk factors do not appear to be additive (OR: 1.39 [95 CI 0.75; 2.46]). Longitudinal studies with larger numbers of participants are needed.

Publisher

Research Square Platform LLC

Reference10 articles.

1. Attention-deficit hyperactivity disorder;Posner J;Lancet,2020

2. Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD);Cabana-Domínguez J;Transl Psychiatry,2022

3. Association of Maternal Autoimmune Disease With Attention-Deficit/Hyperactivity Disorder in Children;Nielsen TC;JAMA Pediatr,2021

4. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders;Han VX;Nat Rev Neurol,2021

5. Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study;Pierrat V;BMJ,2021